**Question:** Drug of choice for Trigeminal neuralgia is:

A. Carbamazepine
B. Gabapentin
C. Pregabalin
D. Amitriptyline

**Correct Answer:** A. Carbamazepine

**Core Concept:**
Trigeminal neuralgia (TN) is a chronic facial pain disorder characterized by sudden, severe, electric shock-like pain in the face, triggered by routine facial movements like talking, eating, or brushing teeth. It is caused by pathology in the trigeminal nerve, typically due to compression or irritation of the nerve root.

**Why the Correct Answer is Right:**
Carbamazepine is a first-line drug of choice for Trigeminal neuralgia due to its specific action on voltage-gated sodium channels, which are crucial in the generation and propagation of pain signals. By blocking these channels, carbamazepine reduces the pain sensitivity and alleviates the symptoms of TN.

**Why Each Wrong Option is Incorrect:**

**Option B (Gabapentin):** Gabapentin is primarily an anticonvulsant and is effective in neuropathic pain, but it lacks the specific action on voltage-gated sodium channels that carbamazepine possesses, making it less effective in treating Trigeminal neuralgia.

**Option C (Pregabalin):** Similar to gabapentin, pregabalin is primarily an anticonvulsant and has limited effects on voltage-gated sodium channels, making it less effective in treating Trigeminal neuralgia compared to carbamazepine.

**Option D (Amitriptyline):** Amitriptyline is an antidepressant that primarily acts on serotonin and norepinephrine reuptake inhibitors. Although it has some neuropathic pain relief, it lacks the specific action on voltage-gated sodium channels, making it less effective in treating Trigeminal neuralgia.

**Clinical Pearl:** Carbamazepine is a first-line drug for Trigeminal neuralgia due to its specific action on voltage-gated sodium channels, targeting the underlying pathophysiology of the condition. Other options either lack this specific action or have limited efficacy in treating trigeminal neuralgia.